Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amylin to Resubmit Diabetes Treatment to F.D.A.
Amylin to Resubmit Diabetes Treatment to F.D.A.
Amylin to Resubmit Diabetes Treatment to F.D.A.
Submitted by
admin
on July 10, 2011 - 11:28am
Source:
NY Times
News Tags:
Amylin
Bydureon
diabetes
Eli Lilly
Alkermes
Headline:
Amylin to Resubmit Diabetes Treatment to F.D.A.
Do Not Allow Advertisers to Use My Personal information
